(Untitle)● SK Chemical leading domestic bio industry
SK Chemical (CEO and Vice-chairman Kim Chang Geun) has endeavored to advance the domestic vaccine industry and has led the future of bio industry in Korea.
Based on the R&D capacity of developing 3 new drugs SK Chemical has endeavored to develop vaccine and bio medicines with over 80 bio R&D personnel.
Through the established new vaccine production complex and R&D for bio/vaccine area it aims to localize vaccines and to develop next generation vaccines.
SK Chemical started vaccine industry in 2006 by merging Dongsin Pharmaceutical, the leading firm for domestic biological medicines. In 2008, the company merged In2Gen, a representing bio venture company, to accelerate the advancement into the bio medical industry. In 2009, the company recorded its first export of Recombinant bio new medicine to a multinational pharmaceutical company for the first time in Korea.
The advancement of production goes together. Last year the company set up an MOU with Xcellerex (CEO Guy Broadbent), a bio medicine and vaccine production company in the US.
As a result, it enabled to adapt next generation production technology with efficiency and flexibility to change its production line promptly when unexpected epidemics such as swine flu spread.
In 2010, the company was appointed as a participation company for [Customized vaccine raw material production supporting project] sponsored by Gyeongsangbuk-do and Andong-si and promoted by Gyeongbuk Institute for Bio Industry to establish vaccine production complex using cell culture method, a next generation technology.
[Customized vaccine raw material production supporting project] is a government sponsored project that private the business provider carries out to develop and produce national compulsory preventive vaccines to improve national public health and to secure vaccine independency.
When SK Chemical Andong Vaccine Plant with 140million dose size annually is completed in 2013, it will contribute to stable vaccine supply and to advance into overseas markets.
SK Chemical will continue to keep its effort to advance into the global market to show excellence of domestic medicines with accumulated R&D know-how and production advancement.